Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 411 entries
Sorted by: Best Match Show Resources per page
Digital library keyword analysis for visualization education research: Issues and recommendations

discipline specific instruction (e.g., engineering curriculum, social science teachers, geology pedagogy)

Bratt S.
GSID: NjDfzsVJxDYJ
S Bratt - Journal of Applied Research in Higher Education, 2018 - emerald.com

… matched the target criteria and were classified as information visualization pedagogy, that is… and accessible benefits educators who want to improve their instruction and academics who … diaspora from computer science into humanities, business and social sciences has...

Cite
Bratt, S. (2018). Digital library keyword analysis for visualization education research: Issues and recommendations. Journal of Applied Research in Higher Education.
Bratt, Sharon. "Digital library keyword analysis for visualization education research: Issues and recommendations." Journal of Applied Research in Higher Education (2018).
Copy Download .nbib Format: MLA
Evolution of the species?.

Nursing times

Kratz C.
PMID: 3846237
Nurs Times. 1985 Apr 17-23;81(16):suppl 8-9.

No abstract available.

Cite
Kratz C. Evolution of the species?. Nurs Times. 1985;81(16):suppl 8-9
Kratz, C. (1985). Evolution of the species?. Nursing times, 81(16), suppl 8-9.
Kratz, C. "Evolution of the species?." Nursing times vol. 81,16 (1985): suppl 8-9.
Kratz C. Evolution of the species?. Nurs Times. 1985 Apr 17-23;81(16):suppl 8-9. PMID: 3846237.
Copy Download .nbib Format: NLM
The education debate. The shape of things to come.

Nursing times

Kratz C.
PMID: 3847938
Nurs Times. 1985 Jun 19-25;81(25):28-9.

No abstract available.

Cite
Kratz C. The education debate. The shape of things to come. Nurs Times. 1985;81(25):28-9
Kratz, C. (1985). The education debate. The shape of things to come. Nursing times, 81(25), 28-9.
Kratz, C. "The education debate. The shape of things to come." Nursing times vol. 81,25 (1985): 28-9.
Kratz C. The education debate. The shape of things to come. Nurs Times. 1985 Jun 19-25;81(25):28-9. PMID: 3847938.
Copy Download .nbib Format: NLM
Recruit and retain. Teacher troubles.

Nursing times

Kratz C.
PMID: 3194245
Nurs Times. 1988 Sep 14-20;84(37):44-5.

No abstract available.

Cite
Kratz C. Recruit and retain. Teacher troubles. Nurs Times. 1988;84(37):44-5
Kratz, C. (1988). Recruit and retain. Teacher troubles. Nursing times, 84(37), 44-5.
Kratz, C. "Recruit and retain. Teacher troubles." Nursing times vol. 84,37 (1988): 44-5.
Kratz C. Recruit and retain. Teacher troubles. Nurs Times. 1988 Sep 14-20;84(37):44-5. PMID: 3194245.
Copy Download .nbib Format: NLM
Teach yourself.

Nursing times

Kratz C.
PMID: 3853187
Nurs Times. 1985 Dec 11-17;81(50):16-7.

No abstract available.

Cite
Kratz C. Teach yourself. Nurs Times. 1985;81(50):16-7
Kratz, C. (1985). Teach yourself. Nursing times, 81(50), 16-7.
Kratz, C. "Teach yourself." Nursing times vol. 81,50 (1985): 16-7.
Kratz C. Teach yourself. Nurs Times. 1985 Dec 11-17;81(50):16-7. PMID: 3853187.
Copy Download .nbib Format: NLM
Severe phenotype of X-linked dominant chondrodysplasia punctata.

Clinical case reports

Damseh N, Chong K, Marshall C, Kratz L, Teitelbaum R, Shannon P, Kannu P.
PMID: 28878897
Clin Case Rep. 2017 Jul 20;5(9):1435-1437. doi: 10.1002/ccr3.1008. eCollection 2017 Sep.

A prenatally ascertained case representing the more severe end of the X-linked dominant chondrodysplasia punctata (CDPX2).

Cite
Damseh N, Chong K, Marshall C, et al. Severe phenotype of X-linked dominant chondrodysplasia punctata. Clin Case Rep. 2017;5(9):1435-1437doi: 10.1002/ccr3.1008.
Damseh, N., Chong, K., Marshall, C., Kratz, L., Teitelbaum, R., Shannon, P., & Kannu, P. (2017). Severe phenotype of X-linked dominant chondrodysplasia punctata. Clinical case reports, 5(9), 1435-1437. https://doi.org/10.1002/ccr3.1008
Damseh, Nadirah, et al. "Severe phenotype of X-linked dominant chondrodysplasia punctata." Clinical case reports vol. 5,9 (2017): 1435-1437. doi: https://doi.org/10.1002/ccr3.1008
Damseh N, Chong K, Marshall C, Kratz L, Teitelbaum R, Shannon P, Kannu P. Severe phenotype of X-linked dominant chondrodysplasia punctata. Clin Case Rep. 2017 Jul 20;5(9):1435-1437. doi: 10.1002/ccr3.1008. eCollection 2017 Sep. PMID: 28878897; PMCID: PMC5582310.
Copy Download .nbib Format: NLM
Reversing factor Xa inhibitors - clinical utility of andexanet alfa.

Journal of blood medicine

Kaatz S, Bhansali H, Gibbs J, Lavender R, Mahan CE, Paje DG.
PMID: 28979172
J Blood Med. 2017 Sep 13;8:141-149. doi: 10.2147/JBM.S121550. eCollection 2017.

Approximately half of patients started on an oral anticoagulant in the USA now receive one of the newer direct oral anticoagulants (DOACs). Although there is an approved reversal agent for the direct thrombin inhibitor dabigatran, a specific reversal agent...

Cite
Kaatz S, Bhansali H, Gibbs J, et al. Reversing factor Xa inhibitors - clinical utility of andexanet alfa. J Blood Med. 2017;8:141-149doi: 10.2147/JBM.S121550.
Kaatz, S., Bhansali, H., Gibbs, J., Lavender, R., Mahan, C. E., & Paje, D. G. (2017). Reversing factor Xa inhibitors - clinical utility of andexanet alfa. Journal of blood medicine, 8141-149. https://doi.org/10.2147/JBM.S121550
Kaatz, Scott, et al. "Reversing factor Xa inhibitors - clinical utility of andexanet alfa." Journal of blood medicine vol. 8 (2017): 141-149. doi: https://doi.org/10.2147/JBM.S121550
Kaatz S, Bhansali H, Gibbs J, Lavender R, Mahan CE, Paje DG. Reversing factor Xa inhibitors - clinical utility of andexanet alfa. J Blood Med. 2017 Sep 13;8:141-149. doi: 10.2147/JBM.S121550. eCollection 2017. PMID: 28979172; PMCID: PMC5602457.
Copy Download .nbib Format: NLM
Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treatment: A case report and review of the literature.

Molecular genetics and metabolism reports

Katz S, Landau Y, Pode-Shakked B, Pessach IM, Rubinshtein M, Anikster Y, Salem Y, Paret G.
PMID: 27995075
Mol Genet Metab Rep. 2016 Dec 08;10:5-7. doi: 10.1016/j.ymgmr.2016.11.008. eCollection 2017 Mar.

Fatty acid oxidation (FAO) defects often present with multi-system involvement, including several life-threatening cardiac manifestations, such as cardiomyopathy, pericardial effusion and arrhythmias. We report herein a fatal case of cardiac dysfunction and rapid-onset tamponade following an acute illness in...

Cite
Katz S, Landau Y, Pode-Shakked B, et al. Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treatment: A case report and review of the literature. Mol Genet Metab Rep. 2016;10:5-7doi: 10.1016/j.ymgmr.2016.11.008.
Katz, S., Landau, Y., Pode-Shakked, B., Pessach, I. M., Rubinshtein, M., Anikster, Y., Salem, Y., & Paret, G. (2017). Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treatment: A case report and review of the literature. Molecular genetics and metabolism reports, 105-7. https://doi.org/10.1016/j.ymgmr.2016.11.008
Katz, Sharon, et al. "Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treatment: A case report and review of the literature." Molecular genetics and metabolism reports vol. 10 (2017): 5-7. doi: https://doi.org/10.1016/j.ymgmr.2016.11.008
Katz S, Landau Y, Pode-Shakked B, Pessach IM, Rubinshtein M, Anikster Y, Salem Y, Paret G. Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treatment: A case report and review of the literature. Mol Genet Metab Rep. 2016 Dec 08;10:5-7. doi: 10.1016/j.ymgmr.2016.11.008. eCollection 2017 Mar. PMID: 27995075; PMCID: PMC5154967.
Copy Download .nbib Format: NLM
How Relative Value Units Undervalue the Cognitive Physician Visit: A Focus on Inflammatory Bowel Disease.

Gastroenterology & hepatology

Katz S, Melmed G.
PMID: 27231455
Gastroenterol Hepatol (N Y). 2016 Apr;12(4):240-4.

No abstract available.

Cite
Katz S, Melmed G. How Relative Value Units Undervalue the Cognitive Physician Visit: A Focus on Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016;12(4):240-4
Katz, S., & Melmed, G. (2016). How Relative Value Units Undervalue the Cognitive Physician Visit: A Focus on Inflammatory Bowel Disease. Gastroenterology & hepatology, 12(4), 240-4.
Katz, Seymour, and Melmed, Gil. "How Relative Value Units Undervalue the Cognitive Physician Visit: A Focus on Inflammatory Bowel Disease." Gastroenterology & hepatology vol. 12,4 (2016): 240-4.
Katz S, Melmed G. How Relative Value Units Undervalue the Cognitive Physician Visit: A Focus on Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016 Apr;12(4):240-4. PMID: 27231455; PMCID: PMC4872854.
Copy Download .nbib Format: NLM
Data publication consensus and controversies.

F1000Research

Kratz J, Strasser C.
PMID: 25075301
F1000Res. 2014 Apr 23;3:94. doi: 10.12688/f1000research.3979.3. eCollection 2014.

The movement to bring datasets into the scholarly record as first class research products (validated, preserved, cited, and credited) has been inching forward for some time, but now the pace is quickening. As data publication venues proliferate, significant debate...

Cite
Kratz J, Strasser C. Data publication consensus and controversies. F1000Res. 2014;3:94doi: 10.12688/f1000research.3979.3.
Kratz, J., & Strasser, C. (2014). Data publication consensus and controversies. F1000Research, 394. https://doi.org/10.12688/f1000research.3979.3
Kratz, John, and Strasser, Carly. "Data publication consensus and controversies." F1000Research vol. 3 (2014): 94. doi: https://doi.org/10.12688/f1000research.3979.3
Kratz J, Strasser C. Data publication consensus and controversies. F1000Res. 2014 Apr 23;3:94. doi: 10.12688/f1000research.3979.3. eCollection 2014. PMID: 25075301; PMCID: PMC4097345.
Copy Download .nbib Format: NLM
Chronic appendicitis: uncommon cause of chronic abdominal pain.

Therapeutic advances in gastroenterology

Kothadia JP, Katz S, Ginzburg L.
PMID: 25949528
Therap Adv Gastroenterol. 2015 May;8(3):160-2. doi: 10.1177/1756283X15576438.

No abstract available.

Cite
Kothadia JP, Katz S, Ginzburg L. Chronic appendicitis: uncommon cause of chronic abdominal pain. Therap Adv Gastroenterol. 2015;8(3):160-2doi: 10.1177/1756283X15576438.
Kothadia, J. P., Katz, S., & Ginzburg, L. (2015). Chronic appendicitis: uncommon cause of chronic abdominal pain. Therapeutic advances in gastroenterology, 8(3), 160-2. https://doi.org/10.1177/1756283X15576438
Kothadia, Jiten P, et al. "Chronic appendicitis: uncommon cause of chronic abdominal pain." Therapeutic advances in gastroenterology vol. 8,3 (2015): 160-2. doi: https://doi.org/10.1177/1756283X15576438
Kothadia JP, Katz S, Ginzburg L. Chronic appendicitis: uncommon cause of chronic abdominal pain. Therap Adv Gastroenterol. 2015 May;8(3):160-2. doi: 10.1177/1756283X15576438. PMID: 25949528; PMCID: PMC4416293.
Copy Download .nbib Format: NLM
Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.

Current treatment options in gastroenterology

Leung G, Papademetriou M, Chang S, Arena F, Katz S.
PMID: 27709332
Curr Treat Options Gastroenterol. 2016 Dec;14(4):507-534. doi: 10.1007/s11938-016-0109-8.

OPINION STATEMENT: As new and effective novel therapies in inflammatory bowel disease (IBD) become available, patients are living longer with advancing age and are at increased risk for malignancy. The management of IBD and malignancy involves multiple combinations of...

Cite
Leung G, Papademetriou M, Chang S, et al. Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy. Curr Treat Options Gastroenterol. 2016;14(4):507-534doi: 10.1007/s11938-016-0109-8.
Leung, G., Papademetriou, M., Chang, S., Arena, F., & Katz, S. (2016). Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy. Current treatment options in gastroenterology, 14(4), 507-534. https://doi.org/10.1007/s11938-016-0109-8
Leung, Galen, et al. "Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy." Current treatment options in gastroenterology vol. 14,4 (2016): 507-534. doi: https://doi.org/10.1007/s11938-016-0109-8
Leung G, Papademetriou M, Chang S, Arena F, Katz S. Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy. Curr Treat Options Gastroenterol. 2016 Dec;14(4):507-534. doi: 10.1007/s11938-016-0109-8. PMID: 27709332.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 411 entries